• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非洲阿尔茨海默病及阿尔茨海默病相关痴呆症研究伦理规范的范围审查

Scoping review of the ethical regulations for Alzheimer's Disease and Alzheimer's Disease Related Dementia research in Africa.

作者信息

Yakubu Aminu, Adedeji Isaac, Jegede Ayodele, Mendoza-Carvantes Diana, Adebamowo Clement

出版信息

Dev World Bioeth. 2024 Oct 9. doi: 10.1111/dewb.12465.

DOI:10.1111/dewb.12465
PMID:39382212
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11978909/
Abstract

We conducted a scoping review to ascertain the landscape of ethics regulations for AD/ADRD research in Africa using Arksey and O'Malley's framework. We sourced regulations from the International Compilation of Human Research Standards. We included regulations from 14 countries published between 1997 and 2020. Provisions in the regulations applicable to research in AD/ADRD were part of broader sub-provisions for research such as with persons under legal disability. Regulations mostly required the appointment of Legally Authorised Representatives, as a major protection for persons with AD/ADRD. Provisions supporting capacity assessment and advance directives were only provided in regulations from five and two countries respectively. No regulation cited the Convention on the Rights of Persons with Disabilities as a foundational instrument for its provisions. In conclusion, regulations specifically applicable to research among AD/ADRD or other cognitively impaired persons in Africa are scarce and provisions in existing regulations mostly lack specificity for practical implementation.

摘要

我们使用阿克西和奥马利的框架进行了一项范围审查,以确定非洲痴呆症/老年痴呆症相关研究的伦理规范情况。我们从《国际人类研究标准汇编》中获取规范。我们纳入了1997年至2020年间14个国家发布的规范。适用于痴呆症/老年痴呆症研究的规范条款是更广泛的研究子条款的一部分,比如涉及法律上无行为能力者的研究。规范大多要求指定法定授权代表,作为对痴呆症/老年痴呆症患者的主要保护措施。分别只有五个国家和两个国家的规范中提供了支持能力评估和预先指示的条款。没有任何规范将《残疾人权利公约》作为其条款的基础文书引用。总之,非洲专门适用于痴呆症/老年痴呆症患者或其他认知障碍者研究的规范很少,现有规范中的条款大多缺乏实际执行的具体性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a83/12407046/9245fbe4a1a4/DEWB-25-179-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a83/12407046/9245fbe4a1a4/DEWB-25-179-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a83/12407046/9245fbe4a1a4/DEWB-25-179-g001.jpg

相似文献

1
Scoping review of the ethical regulations for Alzheimer's Disease and Alzheimer's Disease Related Dementia research in Africa.非洲阿尔茨海默病及阿尔茨海默病相关痴呆症研究伦理规范的范围审查
Dev World Bioeth. 2024 Oct 9. doi: 10.1111/dewb.12465.
2
Ethical issues in genomics research in persons with Alzheimer's Disease/Alzheimer's Disease-related dementia (AD/ADRD): a systematic review.阿尔茨海默病/阿尔茨海默病相关痴呆(AD/ADRD)患者中基因组学研究的伦理问题:系统评价。
BMC Med Ethics. 2024 Nov 25;25(1):138. doi: 10.1186/s12910-024-01141-w.
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).¹⁸F - 氟代脱氧葡萄糖正电子发射断层显像(¹⁸F - FDG PET)用于轻度认知障碍(MCI)患者中阿尔茨海默病性痴呆及其他痴呆的早期诊断。
Cochrane Database Syst Rev. 2015 Jan 28;1(1):CD010632. doi: 10.1002/14651858.CD010632.pub2.
5
Pharmacotherapies for sleep disturbances in Alzheimer's disease.用于治疗阿尔茨海默病睡眠障碍的药物疗法。
Cochrane Database Syst Rev. 2014 Mar 21(3):CD009178. doi: 10.1002/14651858.CD009178.pub2.
6
Galantamine for dementia due to Alzheimer's disease and mild cognitive impairment.加兰他敏治疗阿尔茨海默病所致痴呆和轻度认知障碍。
Cochrane Database Syst Rev. 2024 Nov 5;11(11):CD001747. doi: 10.1002/14651858.CD001747.pub4.
7
Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).血浆和脑脊液β淀粉样蛋白用于诊断轻度认知障碍(MCI)患者的阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2014 Jun 10;2014(6):CD008782. doi: 10.1002/14651858.CD008782.pub4.
8
Nimodipine for primary degenerative, mixed and vascular dementia.尼莫地平用于原发性退行性、混合型和血管性痴呆。
Cochrane Database Syst Rev. 2001(1):CD000147. doi: 10.1002/14651858.CD000147.
9
Developing biobanking processes for Alzheimer's disease and related dementia research in Africa: Experience from the Recruitment and Retention for Alzheimer's Disease Diversity in the Alzheimer's Disease Sequencing Project (READD-ADSP).为非洲阿尔茨海默病及相关痴呆症研究开发生物样本库流程:阿尔茨海默病测序项目中阿尔茨海默病多样性招募与保留研究(READD-ADSP)的经验。
Alzheimers Dement. 2025 Aug;21(8):e70559. doi: 10.1002/alz.70559.
10
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).脑脊液tau蛋白及脑脊液tau蛋白与β淀粉样蛋白比值在轻度认知障碍(MCI)患者中用于诊断阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Mar 22;3(3):CD010803. doi: 10.1002/14651858.CD010803.pub2.

本文引用的文献

1
Strengthening ethics committees for health-related research in sub-Saharan Africa: a scoping review.加强撒哈拉以南非洲与健康相关研究的伦理委员会:范围综述。
BMJ Open. 2022 Nov 21;12(11):e062847. doi: 10.1136/bmjopen-2022-062847.
2
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019.2019 年全球痴呆症患病率估计及 2050 年预测患病率:2019 年全球疾病负担研究分析。
Lancet Public Health. 2022 Feb;7(2):e105-e125. doi: 10.1016/S2468-2667(21)00249-8. Epub 2022 Jan 6.
3
Advance research directives: avoiding double standards.
预先指示研究:避免双重标准。
BMC Med Ethics. 2021 Oct 9;22(1):137. doi: 10.1186/s12910-021-00704-5.
4
The theorisation of 'best interests' in bioethical accounts of decision-making.论生物伦理决策中“最佳利益”的理论化。
BMC Med Ethics. 2021 Jun 1;22(1):68. doi: 10.1186/s12910-021-00636-0.
5
The full spectrum of ethical issues in dementia research: findings of a systematic qualitative review.痴呆症研究中的伦理问题全貌:一项系统性定性综述的结果
BMC Med Ethics. 2021 Mar 26;22(1):32. doi: 10.1186/s12910-020-00572-5.
6
Supported Decision-Making and Paradigm Shifts: Word Play or Real Change?支持性决策与范式转变:文字游戏还是真正的变革?
Front Psychiatry. 2021 Jan 11;11:571005. doi: 10.3389/fpsyt.2020.571005. eCollection 2020.
7
Dementia, Treatment Decisions, and the UN Convention on the Rights of Persons With Disabilities. A New Framework for Old Problems.痴呆症、治疗决策与《联合国残疾人权利公约》。解决老问题的新框架。
Front Psychiatry. 2020 Nov 9;11:571722. doi: 10.3389/fpsyt.2020.571722. eCollection 2020.
8
Ethical and legal aspects of research involving older people with cognitive impairment: A survey of dementia researchers in Australia.涉及认知障碍老年人的研究的伦理和法律方面:澳大利亚痴呆症研究人员的调查。
Int J Law Psychiatry. 2020 Jan-Feb;68:101534. doi: 10.1016/j.ijlp.2019.101534. Epub 2019 Dec 11.
9
Dementia spectrum disorders: lessons learnt from decades with PET research.痴呆谱系障碍:从数十年的 PET 研究中吸取的经验教训。
J Neural Transm (Vienna). 2019 Mar;126(3):233-251. doi: 10.1007/s00702-019-01975-4. Epub 2019 Feb 14.
10
Consent recommendations for research and international data sharing involving persons with dementia.涉及痴呆症患者的研究和国际数据共享的同意书建议。
Alzheimers Dement. 2018 Oct;14(10):1334-1343. doi: 10.1016/j.jalz.2018.05.011. Epub 2018 Jul 2.